• HBsAg-TBK1 Interaction Drives Immune Suppression and Early A

  2026-05-28

  This study uncovers how hepatitis B surface antigen (HBsAg) manipulates TANK-binding kinase 1 (TBK1) to suppress type I interferon signaling and induce early, incomplete autophagy. The findings provide critical mechanistic insight into HBV's immune evasion and highlight new experimental directions for dissecting autophagy-innate immunity crosstalk.

• Phosbind Acrylamide: Advancing Protein Phosphorylation Analy

  2026-05-28

  Phosbind Acrylamide empowers antibody-free, high-precision protein phosphorylation analysis during SDS-PAGE, enabling researchers to resolve dynamic phosphorylation states efficiently. Its robust phosphate-binding mechanism streamlines detection workflows, particularly for posttranslational signaling studies and kinase activity assays.

• EZ Cap™ EGFP mRNA (5-moUTP): High-Efficiency mRNA Expression

  2026-05-27

  EZ Cap™ EGFP mRNA (5-moUTP) is a synthetic enhanced green fluorescent protein mRNA optimized for robust, immune-evasive gene expression. Its Cap 1 structure and 5-methoxyuridine modifications deliver superior translation efficiency and stability, supporting demanding applications in mRNA delivery, translation assays, and in vivo imaging.

• PP 1 Src Family Tyrosine Kinase Inhibitor: Precision in Canc

  2026-05-27

  PP 1 delivers nanomolar-selective inhibition of Src-family kinases, empowering researchers to dissect oncogenic and immune signaling in advanced cancer models. This guide translates bench findings into optimized experimental protocols and actionable troubleshooting strategies, making PP 1 (A8215) from APExBIO an essential tool for translational cancer and immunology research.

• Eliminating Pollen Interference in EEM Fluorescence Detectio

  2026-05-26

  Zhang et al. introduce a robust workflow to identify and remove pollen-induced spectral interference in excitation–emission matrix (EEM) fluorescence spectroscopy, markedly improving hazardous bioaerosol classification. Their approach enhances detection accuracy for hazardous substances, including toxins and bacteria, with direct implications for rapid public health monitoring.

• Practical Guide: Cell Counting Kit-8 (CCK-8) Plus for Cell A

  2026-05-26

  The Cell Counting Kit-8 (CCK-8) Plus enables rapid, quantitative measurement of cell viability, proliferation, and cytotoxicity using a sensitive, water-soluble tetrazolium salt assay. It is well-suited for high-throughput screening and precise cell-based assays across diverse cell types, but should not be used where metabolic activity does not correlate with cell number or in non-enzymatic viability contexts.

• ABT-263 (Navitoclax): Precision Apoptosis Tools for Cancer R

  2026-05-25

  ABT-263 (Navitoclax) is redefining apoptosis research by enabling highly selective and quantifiable cell death assays in cancer biology. Its nanomolar Bcl-2 family inhibition and robust performance in pediatric leukemia models make it the preferred tool for dissecting mitochondrial apoptosis, troubleshooting resistance, and accelerating translational workflows.

• Protease Inhibitor Cocktail EDTA-Free: Advanced Bench Workfl

  2026-05-25

  APExBIO’s Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) redefines reliable protein extraction for phosphorylation-sensitive and post-translational modification workflows. Its EDTA-free, broad-spectrum formulation uniquely preserves protein integrity in even the most challenging biological samples.

• Mechanistic Leverage: Next-Gen mRNA Reporters in Translation

  2026-05-24

  This thought-leadership article examines how the design of EZ Cap™ EGFP mRNA (5-moUTP) advances translational research by uniting mechanistic innovation and workflow reproducibility. We explore recent breakthroughs in mRNA delivery and immune evasion, connect cutting-edge mechanistic insights to laboratory protocols, and provide strategic guidance for researchers seeking robust, quantifiable gene expression in complex biological systems.

• Golgi-Tracker Green: Photostable Live-Cell Golgi Imaging Sol

  2026-05-23

  Golgi-Tracker Green empowers researchers with highly specific, photostable live-cell Golgi apparatus labeling, outperforming conventional probes in clarity and reproducibility. Its BODIPY FL-labeled C5-ceramide foundation enables robust workflows for lipid transport and sphingolipid metabolism analysis.

• Omeprazole: Technical Guide for H+,K+-ATPase Inhibition

  2026-05-22

  Omeprazole (SKU A2845) is a potent H+,K+-ATPase inhibitor used in research to study gastric acid secretion and antiulcer mechanisms. This product is best suited for controlled laboratory assays modeling peptic ulcer disease and related gastric acid disorders, but should not be used for diagnostic or medical applications. Researchers must account for its solubility, storage stability, and workflow integration to ensure reproducible results.

• Enhancing Kidney-Targeted mRNA Nanoparticle Loading via Exci

  2026-05-22

  This study explores how excipients modulate the mRNA loading capacity of polymeric mesoscale nanoparticles for kidney-targeted delivery. The findings demonstrate that certain excipients improve mRNA encapsulation and stability while maintaining nanoparticle size, offering promising advances for renal gene therapy platforms.

• EZ Cap™ mCherry mRNA: Precision Red Fluorescent Protein Expr

  2026-05-21

  Discover how EZ Cap™ mCherry mRNA enables reliable red fluorescent protein expression with enhanced mRNA stability and minimal immune activation. This article bridges advanced assay needs with the latest biosensor and reporter gene innovations.

• Amyloid Beta-Peptide (1-40) (human): Applied Workflows & Inn

  2026-05-21

  Amyloid Beta-Peptide (1-40) (human) from APExBIO enables robust, reproducible modeling of amyloid aggregation and neurotoxicity, empowering translational Alzheimer's disease research. Discover advanced workflow enhancements, real-world troubleshooting, and actionable protocol tips grounded in cutting-edge studies.

• DOT1L Inhibition Primes Immunity, Enhances Lenalidomide Resp

  2026-05-20

  This study demonstrates that targeting DOT1L, an epigenetic methyltransferase, activates innate immune signaling and amplifies the anti-myeloma efficacy of lenalidomide. The findings suggest that combining DOT1L inhibition with immunomodulatory drugs could address resistance mechanisms and improve multiple myeloma outcomes.

668 records 10/45 page Previous Next First page 上5页 678910 下5页 Last page